Finance

Lists
HNSA:STO
Hansa Biopharma AB
၄၆.၈၄ SEK
+၁.၂၁%
(+၀.၅၆) 1D
နို ၁၃, GMT+၁ ၁၇:၂၉:၅၆  ·   SEK
All symbols
SymbolPriceChange% Change
Generating top insights for HNSA...
Open
၄၆.၅၀ SEK
High
၄၇.၈၄ SEK
Low
၄၂.၇၄ SEK
Mkt. cap
၄၇၆.၆၆ ဋေ
Avg. vol.
၆.၁၆ သိန်း
Volume
၁.၂၈ သန်း
52-wk high
၄၉.၃၂ SEK
52-wk low
၂၃.၅၂ SEK
EPS
-၇.၉၀ SEK
Shares outstanding
၁၀.၁၈ ကုဋေ
No. of employees
၁၃၁
Open
၄၆.၅၀ SEK
High
၄၇.၈၄ SEK
Low
၄၂.၇၄ SEK
Mkt. cap
၄၇၆.၆၆ ဋေ
Avg. vol.
၆.၁၆ သိန်း
Volume
၁.၂၈ သန်း
52-wk high
၄၉.၃၂ SEK
52-wk low
၂၃.၅၂ SEK
EPS
-၇.၉၀ SEK
Shares outstanding
၁၀.၁၈ ကုဋေ
No. of employees
၁၃၁
News stories
From web sources and news partners
GuruFocus
GuruFocus
·
ပြီးခဲ့သည့် ၁ ရက်
Hansa Biopharma AB (HNSBF) (Q3 2026) Earnings Call Highlights: C
Investing.com
Investing.com
·
ပြီးခဲ့သည့် ၂ ရက်
Earnings call transcript: Hansa Biopharma Q3 2026 loss misses forecast as stock rises
Yahoo Finance
Yahoo Finance
·
ပြီးခဲ့သည့် ၂ ရက်
Hansa Biopharma Reports Third Quarter and Interim Year to Date 2026 Financial Results
TradingView
TradingView
·
ပြီးခဲ့သည့် ၂ ရက်
Sweden's Hansa Biopharma Q3 revenue surges on SERB license deal
About Hansa Biopharma AB
CEOSøren Tulstrup
Employees၁၃၁
Founded၂၀၀၇
Headquarters-
SectorHealth Care
Industry-
Previous reportsAll values in SEK
Loading Previous Earnings...
Revenue
Net income
All values in SEK
၂၀၂၅ ဒီ
၂၀၂၆ မတ်
၂၀၂၆ ဇွန်
၂၀၂၆ စက်
Revenue
၇.၆၀ ကုဋေ
၃.၄၆ ကုဋေ
၄.၈၁ ကုဋေ
၁၄.၃၀ ကုဋေ
Cost of goods sold
၂.၄၇ ကုဋေ
၁.၃၈ ကုဋေ
၂.၂၃ ကုဋေ
၇.၆၂ ကုဋေ
Cost of revenue
၂.၄၇ ကုဋေ
၁.၃၈ ကုဋေ
၂.၂၃ ကုဋေ
၇.၆၂ ကုဋေ
Research and development expenses
၇.၄၄ ကုဋေ
၅.၇၃ ကုဋေ
၆.၇၉ ကုဋေ
၆.၅၄ ကုဋေ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
၁၀.၁၆ ကုဋေ
၁၀.၅၆ ကုဋေ
၁၁.၈၉ ကုဋေ
၁၄.၇၆ ကုဋေ
Operating expense
၁၇.၆၀ ကုဋေ
၁၆.၂၉ ကုဋေ
၁၈.၆၈ ကုဋေ
၂၀.၅၄ ကုဋေ
Total operating expenses
၂၀.၀၇ ကုဋေ
၁၇.၆၇ ကုဋေ
၂၀.၉၂ ကုဋေ
၂၈.၁၆ ကုဋေ
Operating income
-၁၂.၄၇ ကုဋေ
-၁၄.၂၁ ကုဋေ
-၁၆.၁၁ ကုဋေ
-၁၃.၈၆ ကုဋေ
Other non operating income
-
၁.၃၈ သန်း
-၃.၀၅ ကုဋေ
၃.၁၂ ကုဋေ
EBT including unusual items
-၁၆.၉၅ ကုဋေ
-၁၉.၅၉ ကုဋေ
-၂၅.၉၉ ကုဋေ
-၁၇.၇၉ ကုဋေ
EBT excluding unusual items
-၁၆.၉၅ ကုဋေ
-၁၉.၅၉ ကုဋေ
-၂၅.၉၉ ကုဋေ
-၁၄.၀၀ ကုဋေ
Income tax expense
၃.၉၆ သိန်း
၄.၅၃ သိန်း
၆.၇၇ သိန်း
၆.၂၃ သိန်း
Effective tax rate
-၀.၂၃%
-၀.၂၃%
-၀.၂၆%
-၀.၃၅%
Other operating expenses
-၃.၄၀ သောင်း
-
၂.၈၀ သောင်း
-၇.၅၂ သန်း
Net income
-၁၆.၉၉ ကုဋေ
-၁၉.၆၃ ကုဋေ
-၂၆.၀၅ ကုဋေ
-၁၇.၈၅ ကုဋေ
Net profit margin
-၂၂၃.၅၈%
-၅၆၇.၈၉%
-၅၄၁.၇၁%
-၁၂၄.၈၂%
Earnings per share
-၁.၆၂
-၁.၉၃
-၂.၂၆
-၁.၆၃
Interest and investment income
-
၂.၅၅ သန်း
၃.၂၀ သန်း
-
Interest expense
-၂၀.၈၁ ကုဋေ
-၂.၈၉ ကုဋေ
-၅.၈၅ ကုဋေ
-၃.၂၇ ကုဋေ
Net interest expenses
-၂၀.၈၁ ကုဋေ
-၂.၆၃ ကုဋေ
-၅.၅၃ ကုဋေ
-၃.၂၇ ကုဋေ
Depreciation and amortization charges
-
-
-
-
EBITDA
-၁၂.၄၁ ကုဋေ
-၁၄.၁၅ ကုဋေ
-၁၄.၉၄ ကုဋေ
-၁၂.၆၄ ကုဋေ
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
Google အက်ပ်များ